This paper will detail the antitumoral activities of cannabidiol a non-psychoactive cannabinoid of the cannabis and hemp plants. Cannabidiol appears within great quantities within both the hemp and cannabis plants. It has been recorded in many circumstances as being capable of stimulating CB receptors (CB1 and CB2) within the bodies endocannabinoid system which where discovered in 1990.
Here is the full scientific article if you wish to download it.
Influencing this system is key as it provides balance to the body overall. Cannabidiol also known as CBD for short has been known to stimulate the CB receptors through a chemical reaction which results in more proteins and bodily resources being created or subdued. In the case of inflammation CBD has been known to reduce inflammation by stopping the over production of the proteins needed to fight off certain infections.
Recorded Benefits of Cannabidiol (CBD)
Glioma cells are parts of tumors which originate in the spine (central nervous system) and the brain and are very common among overly infectious tumors. This paper brings to light the exceptional statements that CBD is capable of killing these cells without having any interaction with the cannabinoid receptors mentioned above. It does this by using the LOX pathway and the endocannabinoid system.
Although this study has witnessed CBDs ability to kill the glioma cells successfully further study will be needed as these results have been witnessed in controlled environments under very specific circumstances within rats. One thing that can be said though that if CBD does not kill the cells it will certainly slow their growth through this process as well.
While CBD doesn’t contain psychoactive effects, it’s important to note that the fact that it comes from the cannabis plant, there are traces of THC. Around the world, THC is illegal, most places allow CBD products with less than 0.3% of THC, but this differs country to country.